ITMI912044A1 - Composizione farmaceutica solida per uso orale a base di dapiprazolo - Google Patents

Composizione farmaceutica solida per uso orale a base di dapiprazolo

Info

Publication number
ITMI912044A1
ITMI912044A1 IT002044A ITMI912044A ITMI912044A1 IT MI912044 A1 ITMI912044 A1 IT MI912044A1 IT 002044 A IT002044 A IT 002044A IT MI912044 A ITMI912044 A IT MI912044A IT MI912044 A1 ITMI912044 A1 IT MI912044A1
Authority
IT
Italy
Prior art keywords
dapiprazole
pharmaceutical composition
solid pharmaceutical
oral use
use based
Prior art date
Application number
IT002044A
Other languages
English (en)
Inventor
Leandro Baiocchi
Depalmo Galli
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of ITMI912044A0 publication Critical patent/ITMI912044A0/it
Priority to ITMI912044A priority Critical patent/IT1250701B/it
Priority to AT92202219T priority patent/ATE136778T1/de
Priority to DK92202219.9T priority patent/DK0524696T3/da
Priority to EP92202219A priority patent/EP0524696B1/en
Priority to DE69209916T priority patent/DE69209916T2/de
Priority to US07/917,153 priority patent/US5234927A/en
Priority to CA002074580A priority patent/CA2074580C/en
Priority to JP19827992A priority patent/JP3330977B2/ja
Publication of ITMI912044A1 publication Critical patent/ITMI912044A1/it
Priority to BG98588A priority patent/BG61242B2/bg
Application granted granted Critical
Publication of IT1250701B publication Critical patent/IT1250701B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITMI912044A 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo IT1250701B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo
DE69209916T DE69209916T2 (de) 1991-07-24 1992-07-18 Oral anzuwendende Arzneimittel Dapiprazol enthaltend
DK92202219.9T DK0524696T3 (da) 1991-07-24 1992-07-18 Orale præparater indeholdende dapiprazol
EP92202219A EP0524696B1 (en) 1991-07-24 1992-07-18 Oral compositions containing dapiprazole
AT92202219T ATE136778T1 (de) 1991-07-24 1992-07-18 Oral anzuwendende arzneimittel dapiprazol enthaltend
US07/917,153 US5234927A (en) 1991-07-24 1992-07-20 Solid pharmaceutical composition for oral administration containing dapiprazole
CA002074580A CA2074580C (en) 1991-07-24 1992-07-23 Solid pharmaceutical composition for oral administration containing dapiprazole
JP19827992A JP3330977B2 (ja) 1991-07-24 1992-07-24 ダピプラゾール含有経口投与用固体医薬組成物
BG98588A BG61242B2 (bg) 1991-07-24 1994-02-25 Твърд фармацевтичен състав за орална употреба набаза дапипразол

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Publications (3)

Publication Number Publication Date
ITMI912044A0 ITMI912044A0 (it) 1991-07-24
ITMI912044A1 true ITMI912044A1 (it) 1993-01-25
IT1250701B IT1250701B (it) 1995-04-21

Family

ID=11360418

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912044A IT1250701B (it) 1991-07-24 1991-07-24 Composizione farmaceutica solida per uso orale a base di dapiprazolo

Country Status (9)

Country Link
US (1) US5234927A (it)
EP (1) EP0524696B1 (it)
JP (1) JP3330977B2 (it)
AT (1) ATE136778T1 (it)
BG (1) BG61242B2 (it)
CA (1) CA2074580C (it)
DE (1) DE69209916T2 (it)
DK (1) DK0524696T3 (it)
IT (1) IT1250701B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (it) * 1992-07-30 1996-03-01 Pfizer
US6187774B1 (en) 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
PT1421944E (pt) * 2001-08-27 2008-01-03 Kyowa Chem Ind Co Ltd Comprimidos antiácidos e laxantes que compreendem óxido demagnésio
EP2063861B1 (en) * 2006-09-15 2015-02-25 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
US20100034888A1 (en) * 2006-09-15 2010-02-11 Hubert Clemens Pellikaan Granulate containing a pharmaceutically active substance and method for its manufacture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
IT1094076B (it) * 1978-04-18 1985-07-26 Acraf Cicloalchiltriazoli
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
US4879304A (en) * 1987-05-01 1989-11-07 Angelini Pharmaceuticals Ltd. Ophthalmic compositions and process for preparing
US4879294A (en) * 1988-01-28 1989-11-07 Angelini Pharmaceuticals Ltd. Opthalmic composition
IT1224250B (it) * 1988-06-10 1990-09-26 Acraf Associzione del depiprazolo con la morfina

Also Published As

Publication number Publication date
JPH05194228A (ja) 1993-08-03
IT1250701B (it) 1995-04-21
EP0524696A1 (en) 1993-01-27
EP0524696B1 (en) 1996-04-17
JP3330977B2 (ja) 2002-10-07
ITMI912044A0 (it) 1991-07-24
US5234927A (en) 1993-08-10
CA2074580A1 (en) 1993-01-25
BG61242B2 (bg) 1997-03-31
DE69209916D1 (de) 1996-05-23
ATE136778T1 (de) 1996-05-15
CA2074580C (en) 2002-12-10
DE69209916T2 (de) 1996-12-05
DK0524696T3 (da) 1996-08-12

Similar Documents

Publication Publication Date Title
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
HK1015137A1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha d-neuraminic acid
IL101883A0 (en) Antiviral combinations and pharmaceutical compositions containing them
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
ATE77236T1 (de) Pharmazeutische zusammensetzungen.
IT1226549B (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
PH24377A (en) Formulations suitable for the stabilisation of alpha-interferon
ES2104845T3 (es) Composiciones lipofilas de sales de antibioticos oligosacaridos.
SE9002278D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
CA2046069A1 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
ITMI912044A1 (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
IT1284604B1 (it) Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
DE3773440D1 (de) Pharmazeutische zusammensetzungen fuer suppositorien.
SE9301112D0 (sv) A new composition
DE69318710T2 (de) Antitussivum
DE69300296D1 (de) Thiochromanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
ITRM920535A0 (it) Composizione farmaceutica per la somministrazione attraverso le mucose.
IT1243358B (it) Composizioni farmaceutiche per la somministrazione orale di irudina
ITRM920173A1 (it) Composizione a base di ibuprofen per uso orale.
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960725